| Toward defining the threshold between low and high glucose variability in diabetes L Monnier, C Colette, A Wojtusciszyn, S Dejager, E Renard, N Molinari, ... Diabetes care 40 (7), 832-838, 2017 | 419 | 2017 |
| Precision medicine in the era of artificial intelligence: implications in chronic disease management M Subramanian, A Wojtusciszyn, L Favre, S Boughorbel, J Shan, ... Journal of translational medicine 18, 1-12, 2020 | 273 | 2020 |
| The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes L Monnier, A Wojtusciszyn, C Colette, D Owens Diabetes technology & therapeutics 13 (8), 813-818, 2011 | 196 | 2011 |
| Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a … S Lablanche, MC Vantyghem, L Kessler, A Wojtusciszyn, S Borot, ... The lancet Diabetes & endocrinology 6 (7), 527-537, 2018 | 191 | 2018 |
| Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts A Wojtusciszyn, M Armanet, P Morel, T Berney, D Bosco Diabetologia 51, 1843-1852, 2008 | 180 | 2008 |
| Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL network S Lablanche, S Borot, A Wojtusciszyn, F Bayle, R Tétaz, L Badet, ... Diabetes care 38 (9), 1714-1722, 2015 | 144 | 2015 |
| Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial E Bosi, P Choudhary, HW De Valk, S Lablanche, J Castañeda, S De Portu, ... The lancet Diabetes & endocrinology 7 (6), 462-472, 2019 | 120 | 2019 |
| Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials PY Benhamou, L Milliat‐Guittard, A Wojtusciszyn, L Kessler, C Toso, ... Diabetic medicine 26 (6), 617-621, 2009 | 86 | 2009 |
| Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol C Toso, R Baertschiger, P Morel, D Bosco, M Armanet, A Wojtusciszyn, ... American journal of transplantation 6 (5), 1049-1058, 2006 | 86 | 2006 |
| Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial L Badet, PY Benhamou, A Wojtusciszyn, R Baertschiger, L Milliat-Guittard, ... Transplantation 84 (1), 89-96, 2007 | 82 | 2007 |
| Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies J Bousquet, C Jorgensen, M Dauzat, A Cesario, T Camuzat, R Bourret, ... Current pharmaceutical design 20 (38), 5928-5944, 2014 | 72 | 2014 |
| The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1 T Brun, KHH He, R Lupi, B Boehm, A Wojtusciszyn, N Sauter, M Donath, ... Human molecular genetics 17 (4), 478-489, 2008 | 72 | 2008 |
| Respective contributions of glycemic variability and mean daily glucose as predictors of hypoglycemia in type 1 diabetes: are they equivalent? L Monnier, A Wojtusciszyn, N Molinari, C Colette, E Renard, D Owens Diabetes Care 43 (4), 821-827, 2020 | 59 | 2020 |
| Proteasome dysfunction mediates high glucose-induced apoptosis in rodent beta cells and human islets C Broca, E Varin, M Armanet, C Tourrel-Cuzin, D Bosco, S Dalle, ... PloS one 9 (3), e92066, 2014 | 58 | 2014 |
| Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d … A Wojtusciszyn, J Branchereau, L Esposito, L Badet, F Buron, ... Diabetes & metabolism 45 (3), 224-237, 2019 | 53 | 2019 |
| SGLT2 is not expressed in pancreatic α-and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans H Chae, R Augustin, E Gatineau, E Mayoux, M Bensellam, N Antoine, ... Molecular metabolism 42, 101071, 2020 | 45 | 2020 |
| Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network S Borot, N Niclauss, A Wojtusciszyn, C Brault, S Demuylder-Mischler, ... Transplantation 92 (9), 1031-1038, 2011 | 44 | 2011 |
| Computer-assisted digital image analysis to quantify the mass and purity of isolated human islets before transplantation N Niclauss, A Sgroi, P Morel, R Baertschiger, M Armanet, A Wojtusciszyn, ... Transplantation 86 (11), 1603-1609, 2008 | 44 | 2008 |
| Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control T Berney, A Mamin, AMJ Shapiro, B Ritz-Laser, MC Brulhart, C Toso, ... American journal of transplantation 6 (7), 1704-1711, 2006 | 44 | 2006 |
| Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and … A Wojtusciszyn, G Mourad, J Bringer, E Renard Diabetes & metabolism 39 (5), 404-410, 2013 | 43 | 2013 |
